Silk Road Medical Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. I'm very happy to host for the first time at the conference Silk Road as a public company, and my pleasure to introduce Erica Rogers, the CEO.
Thank you, Robbie, and let me start by saying thank you for attending here late in the day, and it is my honor and privilege to be in front of all of you and certainly my honor to talk about Silk Road Medical. So let's get right into it.
Silk Road Medical is establishing an entirely new, minimally invasive procedural category. And we believe that this category, this new procedure has the possibility to become the standard of care. And that procedure is known as TCAR, TransCarotid Artery Revascularization, for the prevention of stroke. And because we believe that this procedure has the possibility to become the standard of care in the treatment of carotid artery disease, we take outcomes very
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
